image
Healthcare - Biotechnology - NASDAQ - US
$ 6.53
-8.16 %
$ 237 M
Market Cap
-1.62
P/E
BALANCE SHEET
200 M ASSETS
54.61%
30.7 M LIABILITIES
47.78%
169 M EQUITY
55.92%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Biomea Fusion, Inc.
image
Current Assets 179 M
Cash & Short-Term Investments 177 M
Receivables 0
Other Current Assets 2.32 M
Non-Current Assets 20.7 M
Long-Term Investments 370 K
PP&E 14.9 M
Other Non-Current Assets 5.5 M
Current Liabilities 22.9 M
Accounts Payable 6.85 M
Short-Term Debt 4.93 M
Other Current Liabilities 11.1 M
Non-Current Liabilities 7.83 M
Long-Term Debt 7.83 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 176.9 113.4 175.7 61.7 0.2
Short Term Investments 0 1.1 27.8 0 0
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 2.3 4.8 6.1 0.5 11 K
Total Current Assets 179.2 117.8 176.6 62.2 0.3
PP&E 14.9 8.0 5.7 0.3 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0.4 0.4 1.9 0 0
Other Long Term Assets 2.5 3.5 1.6 12 K 0
Other Assets 1 0 0 0 0
Total Assets 199.9 129.3 185.7 62.5 0.3
LIABILITIES
Accounts Payable 6.9 6.8 1.3 0.7 0.3
Short Term Debt 4.9 1.2 1.1 0.3 0
Other Current Liabilities 11.1 11.0 2.2 0.6 15 K
Total Current Liabilities 22.9 19.1 4.6 1.6 0.3
Long Term Debt 7.8 1.7 2.3 0 0
Deferred Tax Income 0 0.5 0.6 0 0
Other Liabilities 0 0 0 0 0
Total Liabilities 30.7 20.8 6.9 57.4 0.3
EQUITY
Common Stock 4 K 3 K 3 K 1 K 1 K
Retained Earnings (248.8) (131.6) (49.7) (8.2) (2.9)
Other Accumulative Comprehensive Income/Loss 0 1 K 10 K 55.7 K 0
Total Equity 169.2 108.5 178.8 5.2 21 K
Total Liabilities and Equity 199.9 129.3 185.7 62.5 0.3
SHARES OUTSTANDING
Common Shares Outstanding 34.1 29.3 23.9 10.7 10.7